EFMH
PRAX icon

E Fund Management (HK)’s Praxis Precision Medicines PRAX Stock Holding History

E Fund Management (HK)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1K Buy
66
+20
+43% +$6.33K 0.01% 297
2026
Q1 		$14.8K Buy
+46
New +$14.2K 0.01% 258

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

E Fund Management (HK)'s PRAX Position: Q2 2026 in Review

E Fund Management (HK) increased its Praxis Precision Medicines (PRAX) stake by 43% in Q2 2026, buying an estimated $6.33K and bringing the position to 66 shares worth $22.1K. The position accounts for 0.01% of the portfolio, ranked #297.

E Fund Management (HK) first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • E Fund Management (HK) held 66 shares of Praxis Precision Medicines worth $22.1K as of Q2 2026.
  • E Fund Management (HK) bought 20 Praxis Precision Medicines shares in Q2 2026, an estimated $6.33K.
  • Praxis Precision Medicines made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #297 holding.
  • E Fund Management (HK) first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.